Top 10 Trends in Medicine, September 2014

Ryan Syrek


September 23, 2014

#3 Clinical Trend: Cologuard

Cologuard was recently approved by the US Food and Drug Administration (FDA) as a stool-based colorectal cancer screening tool. It analyzes specimens to detect hemoglobin, multiple DNA methylation and mutational markers, and the total amount of human DNA contained in cells that are shed by colorectal carcinomas or advanced adenomas into the colon.

For more in-depth clinical information, see Colon Cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.